No abstract available
Keywords:
COVID-19; SARS-CoV-2; methylprednisolone; survival; tocilizumab.
MeSH terms
-
Antibodies, Monoclonal, Humanized
-
COVID-19*
-
China
-
Humans
-
Methylprednisolone
-
Pneumonia* / drug therapy
-
Respiratory Distress Syndrome*
-
Risk Factors
-
SARS-CoV-2
Substances
-
Antibodies, Monoclonal, Humanized
-
tocilizumab
-
Methylprednisolone